PHARMACO-EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA: THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY PIFAGOR III

This paper presents the results of the pharmaco-epidemiological study of arterial hypertension (AH) in Russia (PIFAGOR III). The survey included both doctors (961 questionnaires) and patients with AH (3030 questionnaires) from 38 Russian cities. The pharmacological therapy analysis demonstrated that...

Full description

Bibliographic Details
Main Authors: M. V. Leonova, Yu. B. Belousov, L. L. Steinberg, A. A. Galitskyi, D. Yu. Belousov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2011-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1096
_version_ 1826561495703486464
author M. V. Leonova
Yu. B. Belousov
L. L. Steinberg
A. A. Galitskyi
D. Yu. Belousov
author_facet M. V. Leonova
Yu. B. Belousov
L. L. Steinberg
A. A. Galitskyi
D. Yu. Belousov
author_sort M. V. Leonova
collection DOAJ
description This paper presents the results of the pharmaco-epidemiological study of arterial hypertension (AH) in Russia (PIFAGOR III). The survey included both doctors (961 questionnaires) and patients with AH (3030 questionnaires) from 38 Russian cities. The pharmacological therapy analysis demonstrated that the most widely prescribed classes of antihypertensives are ACE inhibitors, beta-adrenoblockers, diuretics, and calcium antagonists. Angiotensin II receptor antagonists are prescribed more often, while “old” drugs with central mechanism of antihypertensive action become less popular. Detailed analysis was performed for each class of antihypertensive agents. In particular, the majority of the patients taking ACE inhibitors receive enalapril (44%). The most popular agents among beta-blockers are bisoprolol (41%) and metoprolol (31,9%), among calcium antagonists – amlodipine (53%), and among diuretics – indapamide (67%). The frequency of original medication prescription was 46% and 39%, based on the survey data for doctors and patients, respectively. An increase was observed in the proportion of AH patients receiving long-term (79%) and combined (74%) antihypertensive therapy. Average number of antihypertensive drugs taken by a patient with AH increased from 1,72 in 2002 to 2,22. Target blood pressure levels (<140/90 mm Hg) were achieved in 69%. Patients’ awareness of AH and its complications, as well as patients’ motivation and therapy compliance, has also increased. In 58% of the patients, the monthly cost of AH medications is under 5000 roubles.
first_indexed 2024-04-09T20:52:10Z
format Article
id doaj.art-75962922f4df4ca7b5326556a8afd074
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2025-03-14T09:33:05Z
publishDate 2011-04-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-75962922f4df4ca7b5326556a8afd0742025-03-02T11:42:28Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202011-04-0102916902PHARMACO-EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA: THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY PIFAGOR IIIM. V. Leonova0Yu. B. Belousov1L. L. Steinberg2A. A. Galitskyi3D. Yu. Belousov4ГОУ ВПО РГМУ РосздраваГОУ ВПО РГМУ РосздраваГОУ ВПО РГМУ РосздраваГОУ ВПО РГМУ РосздраваРоссийское общество клинических исследователейThis paper presents the results of the pharmaco-epidemiological study of arterial hypertension (AH) in Russia (PIFAGOR III). The survey included both doctors (961 questionnaires) and patients with AH (3030 questionnaires) from 38 Russian cities. The pharmacological therapy analysis demonstrated that the most widely prescribed classes of antihypertensives are ACE inhibitors, beta-adrenoblockers, diuretics, and calcium antagonists. Angiotensin II receptor antagonists are prescribed more often, while “old” drugs with central mechanism of antihypertensive action become less popular. Detailed analysis was performed for each class of antihypertensive agents. In particular, the majority of the patients taking ACE inhibitors receive enalapril (44%). The most popular agents among beta-blockers are bisoprolol (41%) and metoprolol (31,9%), among calcium antagonists – amlodipine (53%), and among diuretics – indapamide (67%). The frequency of original medication prescription was 46% and 39%, based on the survey data for doctors and patients, respectively. An increase was observed in the proportion of AH patients receiving long-term (79%) and combined (74%) antihypertensive therapy. Average number of antihypertensive drugs taken by a patient with AH increased from 1,72 in 2002 to 2,22. Target blood pressure levels (<140/90 mm Hg) were achieved in 69%. Patients’ awareness of AH and its complications, as well as patients’ motivation and therapy compliance, has also increased. In 58% of the patients, the monthly cost of AH medications is under 5000 roubles.https://russjcardiol.elpub.ru/jour/article/view/1096arterial hypertensionpharmaco-epidemiologyantihypertensive medications
spellingShingle M. V. Leonova
Yu. B. Belousov
L. L. Steinberg
A. A. Galitskyi
D. Yu. Belousov
PHARMACO-EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA: THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY PIFAGOR III
Российский кардиологический журнал
arterial hypertension
pharmaco-epidemiology
antihypertensive medications
title PHARMACO-EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA: THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY PIFAGOR III
title_full PHARMACO-EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA: THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY PIFAGOR III
title_fullStr PHARMACO-EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA: THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY PIFAGOR III
title_full_unstemmed PHARMACO-EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA: THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY PIFAGOR III
title_short PHARMACO-EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN RUSSIA: THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY PIFAGOR III
title_sort pharmaco epidemiology of arterial hypertension in russia the results of the pharmacoepidemiological study pifagor iii
topic arterial hypertension
pharmaco-epidemiology
antihypertensive medications
url https://russjcardiol.elpub.ru/jour/article/view/1096
work_keys_str_mv AT mvleonova pharmacoepidemiologyofarterialhypertensioninrussiatheresultsofthepharmacoepidemiologicalstudypifagoriii
AT yubbelousov pharmacoepidemiologyofarterialhypertensioninrussiatheresultsofthepharmacoepidemiologicalstudypifagoriii
AT llsteinberg pharmacoepidemiologyofarterialhypertensioninrussiatheresultsofthepharmacoepidemiologicalstudypifagoriii
AT aagalitskyi pharmacoepidemiologyofarterialhypertensioninrussiatheresultsofthepharmacoepidemiologicalstudypifagoriii
AT dyubelousov pharmacoepidemiologyofarterialhypertensioninrussiatheresultsofthepharmacoepidemiologicalstudypifagoriii